Lack of Myocardial Perfusion Immediately After
Successful Thrombolysis Background. We investigated myocardial perfusion dynamics after thrombolysis and its clinical implications.
Methods and Results. We studied 39 patients with acute anterior myocardial infarction (AMI) . Myocardial contrast echocardiography (MCE) was performed before and immediately after successful reflow with intracoronary injection of sonicated loxaglate. The average segmental score by twodimensional echocardiography (graded 0, normal, to 3, akinetic/dyskinetic) and global ejection fraction (left ventricular ejection fraction, LVEF%Y) by left ventriculography were measured at 1 day and at 4 weeks after reflow. Hypokinesis in the infarct region was assessed by the centerline method and expressed in terms of standard deviations (regional wall motion [RWM : SD/chord) of normal. Immediately after reflow, 30 of 39 patients (group A) showed significant contrast enhancement within the risk area. The other nine patients (23%, group B), however, showed the residual contrast defect in the risk area (myocardial no reflow). There were no significant differences in the elapsed time, angiographic collateral grade, and degree of residual stenosis between group A and group B. Before reflow, both groups exhibited similar levels of global and regional left ventricular function. Improvement in global (LVEF, average segmental score) and regional left ventricular function was greater in group 
Analysis of Myocardial Contrast Echocardiographic Data
Images recorded on videotape were analyzed using a commercially available off-line computer system (model LA-500, PIAS, Osaka). For the assessment of the risk area and residual contrast defect, we used the apical long-axis view of the left ventricle. Because no contrast enhancement was observed in the apical long-axis view after contrast injection into the right coronary artery in this study population, only contrast images obtained from left coronary artery injection were used. To define the risk area region showing no contrast effect before reflow, the end-diastolic frame of the postinjection cycle showing the best delineation between contrastenhanced and nonenhanced myocardium was selected for analysis.
The patients were divided into two groups based on by MCE performed after reflow. The presence or absence of residual contrast defect was the only criterion for patient classification. The measurement used to assess reperfusion was a risk area-length ratio: ratio=(endocardial length of residual contrast defect after reflow)/(endocardial length of defect before reflow). When this length ratio exceeded 0.25, it was considered indicative of incomplete myocardial reperfusion. Other echo planes were used for confirmation of the residual contrast defect.
Reproducibility of Results
The reproducibility of measuring the endocardial length of the contrast defect was assessed in five patients by repeating the injection of sonicated loxaglate. Intraobserver variability was defined by one observer making duplicate measurements in 10 randomly selected images. Interobserver variability was defined by another observer making a single set of measurements. These observers were blinded to patient data and the result of the other observer.
Analysis of Echo Wall Motion
Images recorded on the day after infarction and 4 weeks later were used for the analysis of left ventricular wall motion. The left ventricle was divided into 17 segments (eight segments on each short-axis slice at the levels of the mitral valve, midpapillary muscle, and apical segment on apical long-axis view). Wall motion in each segment was evaluated as follows: 3, akinetic/ dyskinetic; 2, severely hypokinetic; 1, hypokinetic; 0, normal. Average segmental score was determined by two independent observers. In cases of disagreement, consensus was established with a third observer.
Analysis of Catheterization Data
The right anterior oblique views of left ventriculograms obtained immediately after infarction and 4 weeks later were used for the assessment of global and regional left ventricular function. End-diastolic and end-systolic endocardial contours were traced in the frames with maximal and minimum volume, respectively. Left ventricular volume was calculated by the area-length method. Global ejection fraction (left ventricular ejection fraction, LVEF%) was calculated from end-diastolic and end-systolic left ventricular volumes (LVEDV and LVESV) as (LVEDV-LVESV)x100/ LVEDV.
Regional wall motion from the ventriculogram was assessed with the centerline method, using 100 chords.10 Each shortening fraction was normalized to the end-diastolic perimeter of the left ventricle. This normalized motion in the left anterior descending artery bed (chords 10-66) was expressed as standard deviation from the mean value previously determined in 38 agematched normal subjects (regional wall motion: SD/ chord). 
Reproducibility of Results
The mean length of the risk area measured in two sequential injections was 97±22 mm and 99+21 mm, respectively; mean difference between the two was 4.0±3.4 mm. The area of the residual contrast defect was always clearly defined. Mean length of the residual contrast defect in the two sequential injections was 56±16 mm and 57±17 mm, respectively (absolute difference, 4 .4±3.9 mm). Absolute difference in the length of the risk area measured by the same observer at two different times was 2.4+2.2 mm, and that measured by two observers was 4.0+2.4 mm. Absolute difference in the length of the residual contrast defect measured by the same observer at two different times was 2.2±1.9 mm, and that measured by two different observers was 3.0±2.8 mm.
Myocardial Perfusion
The risk area in the anterior interventricular septum, anterior free wall, and cardiac apex was clearly defined as a negative contrast area in all study patients before reflow by the injection of sonicated loxaglate into the left coronary artery.
Significant contrast enhancement was observed within the predetermined risk area immediately after coronary reflow in 30 (77%) of 39 patients. These patients were classified as group A (Figure 1) . In comparison, a sizable contrast defect was noted in nine patients after successful reflow. These patients were classified as group B. 
Recovery in Left Ventricular Function
Changes in the average segmental score between initial and delayed echo studies are summarized in Figure 3 . There was no difference in the average segmental score between group A and group B patients (0.89±0.37 versus 1.07±0.32, NS) in the baseline prereflow study. The group A patients showed a significantly greater improvement in average segmental score compared with group B patients in the delayed study (0.44+0.41 versus 0.97+±0.36, p<0.01). There were no differences in the degree of regional wall motion abnormality in the territory of the left anterior descending coronary artery between group A and group B (-3.26±0.43 SD/chord versus -3.36±0.15 SD/chord, NS) in the baseline study. The group A patients, however, showed less wall motion abnormality than group B patients in the delayed study ( studies"'l2'17 also suggested that the no reflow phenomenon should be related to paucity of microcirculation that has been destroyed by the infarction process. According to these studies, it has been predicted that, in patients with AMI, the recovery of contractile function in the risk area may be worse in those with residual perfusion defects than in those without. In the current study, little or no improvement in global and regional left ventricular function was observed in the patients with residual perfusion defects. Thus, in the patients with AMI, the lack of myocardial perfusion after reflow may be related to lack of microvascular integrity, which may simply mean worse muscle necrosis.
We compared the elapsed time and angiographic collateral grade between patients with and without residual perfusion defects. A previous experimental study'2 suggested that the no reflow phenomenon becomes worse over time and that elapsed time was one of the determinants of no reflow. However, in the current study, there were no differences in the elapsed time or in the grade of angiographic collaterals between patients with and without residual perfusion defect. The study population, however, was limited to patients who achieved thrombolysis within 6 hours of symptom onset, and no patient in this study had well developed collaterals in the initial coronary arteriograms.
It is interesting to note whether patterns of myocardial reperfusion are different between thrombolysis and coronary angioplasty. Residual coronary stenosis, which limits myocardial flow, may be more severe in thrombolysis compared with angioplasty. On Two possible mechanisms may explain the improvement in regional function in patients who did not exhibit perfusion defects after successful reflow. In these patients, ischemic damage to the myocardium and to the coronary microcirculation is less severe compared with the patients with residual contrast defect; therefore, Comparison With Previous Studies Schofer et a118 injected radioactive microalbumin aggregates after intracoronary thrombolysis and demonstrated 9'Tc perfusion defects in all patients. Their prevalence of no reflow was much higher than noted in our study (23%). In contrast to Schofer's study, the majority of our patients (74%) underwent coronary angioplasty. The difference in the severity of residual coronary stenosis may explain the difference in our results. In addition to microvascular damage, perfusion could be limited to a myocardial bed because of severe epicardial stenosis. This phenomenon, however, does not represent the classic no reflow phenomenon.
Limitations
Regional contrast intensity can be influenced by several factors, including 1) the size and number of microbubbles injected, 2) the injection volume of the contrast medium, and 3) factors affecting ultrasonic reflection such as gain setting, depth of penetration, axial and lateral resolution, gray scale compression, and the nonlinearity of echo amplitude. In the current study, the same echo plane and the same intracoronary injection volume of the sonicated microbubbles were used for the determination of presence or absence of contrast perfusion defect. Thus, the effects of the aforementioned factors might have been minimized.
The diameter of the microbubbles produced by sonication in this study was 12±3 ,m, which is larger than red blood cells. Their intravascular rheology, therefore, may be different from that of red cells. New contrast media, such as sonicated albumin, are smaller in size than these microbubbles and are being applied to humans as red cell tracers. 19 These new contrast media should promote better understanding of the flow dynamics of red blood cells in the postischemic microcirculation.
The apical long-axis view during contrast injection into left coronary artery was chosen for risk area assessment in this study, because no contrast enhancement was observed in this echo view after contrast injection into the right coronary artery. In cases with well developed collateral channels that come from the right coronary artery, the risk area may be overestimated with the present method. We should make contrast injection into both right and left coronary arteries in the same echo view for the quantitation of the risk area as an area of contrast defect.
Clinical Applications
Because the absence of adequate myocardial perfusion after successful reflow predicts poor recovery in regional function, patients showing this phenomenon are likely to show infarct expansion and heart failure. Such patients may need aggressive forms of unloading therapy. 20 Several experimental studies indicated that the no reflow phenomenon was significantly attenuated by administration of several drugs (superoxide dismutase and catalase13 or adenosine21). Although these drugs have not been used in clinical settings, MCE might be a promising method in the evaluation of the effect of these interventions on the no reflow phenomenon in experimental as well as in clinical studies.
Using MCE, we can simultaneously assess regional wall motion and myocardial perfusion in patients with AMI. The mechanism of abnormalities in regional motion may be evaluated in relation to the abnormalities in regional perfusion.
The use of MCE in conjunction with coronary arteriography can provide information on regional myocardial blood flow and epicardial coronary anatomy, which might be useful in determining therapeutic strategies.
